Tetra Bio-Pharma Inc.
TBPMQ
$0.00
$0.000.00%
OTC PK
| 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | 08/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 41.61% | 53.92% | 80.47% | -173.29% | 4.90% |
| Total Depreciation and Amortization | -20.56% | -35.45% | 37.30% | 291.78% | 248.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -58.63% | -57.18% | 978.64% | 1,177.89% | -82.54% |
| Change in Net Operating Assets | 201.57% | 123.52% | -124.80% | 74.34% | -486.40% |
| Cash from Operations | 88.82% | 82.80% | 37.77% | 62.59% | -170.33% |
| Capital Expenditure | -- | -- | -- | 76.86% | 15.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 61.44% | 92.95% |
| Cash from Investing | -- | -- | -- | 61.87% | 80.34% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 59.06% | 26.61% | -- | -- |
| Issuance of Common Stock | -100.00% | -98.31% | 10.85% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 99.25% | -- | -- | -- |
| Cash from Financing | -1,465.58% | -100.07% | -59.15% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.22% | -112.41% | 17.22% | 62.46% | -118.79% |